Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival

Nephrology Dialysis Transplantation

Volumn 18, Issue 5, 2003, Pages 990-995

  Fernández Fresnedo, Gema ^a   Pastor, Jose Manuel ^a   López Hoyos, Marcos ^a   Ruiz, Juan Carlos ^a   Zubimendi, Juan Antonio ^a   Gonzalez Cotorruelo, Julio ^a   Rodrigo, Emilio ^a   De Francisco, Angel L M ^a   Arias, Manuel ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Acute rejection; Anti HLA antibodies; Kidney transplantation; Post transplant

Indexed keywords

HLA ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BLOOD VESSEL; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONITORING; OUTCOMES RESEARCH; PATIENT CODING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; BLOOD TRANSFUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS; TISSUE DONORS;

EID: 0038025553     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg068     Document Type: Article

References (20)

1. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA anti-bodies after solid organ transplantation. Transplantation 2000; 69: 319-326
2. Sumitran-Karuppan S. The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies. Transplantation 1999; 68: 502-509
3. Supon P, Constantino D, Hao P et al. Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection. Transplantation 2001; 71: 577-580
4. Worthington JE, Thomas AA, Dyer PA, Martin S. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome. Transplantation 1998; 65: 121-125
5. Schönemann C, Groth J, Leverenz S, May G. HLA class I and class II antibodies. Monitoring before and after kidney transplantation and their clinical relevance. Transplantation 1998; 65: 1519-1523
6. Suciu-Foca N, Reed E, D'Agati VD et al. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 1991; 51: 593-601
7. Monteiro F, Buelow R, Mineiro C, Rodrigues H, Kalil J. Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay. Transplantation 1997; 63: 542-546
8. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allogratt pathology. Kidney Int 1999; 55: 713-723
9. Fernandez-Fresnedo G, Pastor JM, Ruiz JC et al. Differences in anti-CREG antibody formation between transplanted and nontransplanted renal patients. Transplantation 1999; 67: 1188-1190
10. Sumitran-Holgersson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant 2001; 16: 897-904
11. Christiaans MH, Nieman F, Van Hooff JP, Van Den Berg-Loonen EM. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation. Transplantation 2000; 69: 917-927
12. Costa AN, Scolari MP, Iannelli S et al. The presence of postransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies. Transplantation 1997; 63: 167-169
13. Martin S, Dyer PA, Mallick NP, Gokal R, Harris R, Johnson RW. Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome. Transplantation 1987; 44: 50-53
14. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response. II Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992; 53: 550-555
15. Scornik JC, Salomon DR, Lim PB, Howard RJ, Pfaff WW. Posttransplant antidonor antibodies and graft rejection: evaluation by two-color flow cytometry. Transplantation 1989; 47: 287-290
16. Van Kampen CA, Maarschalk MFJV, Roelen DL, Ten Berge IJM, Claas FHJ. Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens. Transplantation 2001; 71: 869-874
17. Reinsmoen N, Kaestner S, Harland R, Matas AJ, Ward FE. Increased risk of acute and chronic rejection in sensitized kidney recipients with HLA class II-directed donor antigen-specific antibodies. In: Terasaki PI, ed. Visuals of the Clinical Histocompatibility Workshop: Palm Springs Invitational. One Lambda Inc., California: 1999: 12
18. Crespo M, Pascual M, Tolkoff-Rubin N et al. Acute humoral rejection in renal allograft recipients. I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652-658
19. Piazza A, Poggi E, Borrelli L et al. Impact of donor-specific antibodies in chronic rejection occurrence and graft loss in renal transplantation. posttransplant analysis using flow cytometric techniques. Transplantation 2001; 71: 1106-1112
20. Luo H, Chen H, Daloze P, Chang JY, St-Louis G, Wu J. Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation 1992; 53: 1071-1076